Markel Group’s CVS Health CVS Stock Holding History

Markel Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-47,000	Closed	-$2.78M	–	134
2024 Q2	$2.78M	Sell	47,000 -285,000	-86%	-$17.8M	0.03%	124
2024 Q1	$26.5M	Hold	332,000	–	–	0.26%	71
2023 Q4	$26.2M	Hold	332,000	–	–	0.29%	69
2023 Q3	$23.2M	Hold	332,000	–	–	0.28%	72
2023 Q2	$23M	Hold	332,000	–	–	0.27%	72
2023 Q1	$24.7M	Hold	332,000	–	–	0.31%	68
2022 Q4	$30.9M	Hold	332,000	–	–	0.41%	62
2022 Q3	$31.7M	Hold	332,000	–	–	0.47%	54
2022 Q2	$30.8M	Hold	332,000	–	–	0.44%	60
2022 Q1	$33.6M	Hold	332,000	–	–	0.4%	60
2021 Q4	$34.2M	Hold	332,000	–	–	0.39%	63
2021 Q3	$28.2M	Hold	332,000	–	–	0.36%	66
2021 Q2	$27.7M	Hold	332,000	–	–	0.35%	67
2021 Q1	$25M	Hold	332,000	–	–	0.35%	67
2020 Q4	$22.7M	Hold	332,000	–	–	0.34%	68
2020 Q3	$19.4M	Hold	332,000	–	–	0.33%	67
2020 Q2	$21.6M	Hold	332,000	–	–	0.4%	60
2020 Q1	$19.7M	Hold	332,000	–	–	0.37%	68
2019 Q4	$24.7M	Buy	332,000 +9,000	+3%	+$632K	0.34%	77
2019 Q3	$20.4M	Buy	323,000 +48,000	+17%	+$2.84M	0.31%	80
2019 Q2	$15M	Hold	275,000	–	–	0.23%	89
2019 Q1	$14.8M	Hold	275,000	–	–	0.25%	84
2018 Q4	$18M	Hold	275,000	–	–	0.34%	69
2018 Q3	$21.6M	Hold	275,000	–	–	0.37%	72
2018 Q2	$17.7M	Hold	275,000	–	–	0.32%	74
2018 Q1	$17.1M	Buy	275,000 +8,000	+3%	+$574K	0.33%	73
2017 Q4	$19.4M	Hold	267,000	–	–	0.37%	65
2017 Q3	$21.7M	Hold	267,000	–	–	0.43%	55
2017 Q2	$21.5M	Buy	267,000 +3,000	+1%	+$237K	0.46%	51
2017 Q1	$20.7M	Buy	264,000 +16,000	+6%	+$1.28M	0.47%	50
2016 Q4	$19.6M	Buy	248,000 +1,000	+0.4%	+$80.9K	0.47%	51
2016 Q3	$22M	Hold	247,000	–	–	0.57%	46
2016 Q2	$23.6M	Hold	247,000	–	–	0.62%	40
2016 Q1	$25.6M	Hold	247,000	–	–	0.69%	38
2015 Q4	$24.1M	Hold	247,000	–	–	0.65%	40
2015 Q3	$23.8M	Hold	247,000	–	–	0.63%	43
2015 Q2	$25.9M	Buy	247,000 +2,000	+0.8%	+$204K	0.65%	43
2015 Q1	$25.3M	Buy	245,000 +13,000	+6%	+$1.32M	0.64%	43
2014 Q4	$22.3M	Buy	232,000 +14,000	+6%	+$1.23M	0.56%	45
2014 Q3	$17.4M	Buy	218,000 +21,000	+11%	+$1.66M	0.49%	50
2014 Q2	$14.8M	Buy	197,000 +101,000	+105%	+$7.63M	0.42%	51
2014 Q1	$7.19M	Buy	+96,000	New	+$6.78M	0.22%	75

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Markel Group's CVS Position: Q3 2024 in Review

Markel Group sold out of CVS Health (CVS) in Q3 2024, closing a stake of 47,000 shares — an estimated $2.78M sold.

Markel Group first reported a position in CVS in Q1 2014 and held it in 42 quarters. The position peaked at $34.2M in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Markel Group reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Markel Group sold 47,000 CVS Health shares in Q3 2024, an estimated $2.78M.
Markel Group first reported a position in CVS Health in Q1 2014 and held it in 42 quarters.
Markel Group's CVS Health position peaked at $34.2M in Q4 2021.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Markel Group's 13F filing for Q3 2024, filed 1 Nov 2024.